Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Healthcare Cannabis
Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Teal Valley > Revised 2022 EPS with added calculation for AISC, Cash Flow
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by maldwynon Jan 26, 2022 10:20pm
158 Views
Post# 34365305

RE:RE:RE:Revised 2022 EPS with added calculation for AISC, Cash Flow

RE:RE:RE:Revised 2022 EPS with added calculation for AISC, Cash Flow Ok thanks for clarifying the 20% by-product rule, I didn't kmow that. Though in Caribou's case I think teh by-product revenue is wel over 20%. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities